Quality of Life Assessment Following Adult Maxillomandibular Advancement for Obstructive Sleep Apnea with Long Term Follow-up

2017 ◽  
Vol 75 (10) ◽  
pp. e347-e348
Author(s):  
N. Robertson ◽  
J.E. Cillo ◽  
D.J. Dattilo
Keyword(s):  
Quality Of Life ◽  
Obstructive Sleep Apnea ◽  
Life Assessment ◽  
Quality Of Life Assessment ◽  
Maxillomandibular Advancement ◽  
Obstructive Sleep ◽  
Long Term Follow Up

Trapezius Port Placement in Patients with Breast Cancer: Long-Term Follow-up and Quality-of-Life Assessment

2019 ◽  
Vol 30 (1) ◽  
pp. 69-73 ◽  
Author(s):  
Barbaros Erhan Çil ◽  
Osman Öcal ◽  
Fatma Gonca Eldem ◽  
Bora Peynircioğlu ◽  
Ferhun Balkancı
Keyword(s):  
Breast Cancer ◽  
Quality Of Life ◽  
Life Assessment ◽  
Port Placement ◽  
Quality Of Life Assessment ◽  
Long Term Follow Up

Multilevel Temperature-Controlled Radiofrequency for Obstructive Sleep Apnea: Extended Follow-Up

2005 ◽  
Vol 132 (4) ◽  
pp. 630-635 ◽  
Author(s):  
David L. Steward ◽  
Edward M. Weaver ◽  
B. Tucker Woodson
Keyword(s):  
Quality Of Life ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Apnea Hypopnea Index ◽  
Obstructive Sleep ◽  
Related Quality ◽  
Temperature Controlled

OBJECTIVE: To determine long-term effectiveness of multilevel (tongue and palate) temperature-controlled radiofrequency tissue ablation (TCRFTA) for patients with obstructive sleep apnea syndrome (OSAS). STUDY DESIGN AND SETTING: Prospective, 2-institution case series. Twenty-nine subjects with mild to moderate OSAS and who were at least 1 year from completion of multilevel TCRFTA were included, representing a subset of subjects who were enrolled in a previously published controlled trial. Exclusion criteria for this extended follow-up study included any additional treatment for OSAS after completion of TCRFTA. RESULTS: Median follow-up was 23 months. Daytime sleepiness and OSAS-related quality of life were significantly improved at extended follow-up (both P 0.001). Median reaction time testing and apnea-hypopnea index (AHI) were also significantly improved at long-term follow-up ( P = 0.03 and 0.01). Body mass index was unchanged ( P = 0.94). CONCLUSIONS: Multilevel TCRFTA treatment of mild to moderate OSAS resulted in prolonged improvement in daytime somnolence, OSAS-related quality of life, psychomotor vigilance, and AHI in this group of subjects at extended follow-up.

Sign in / Sign up

Export Citation Format

Share Document